ArticleAdvances in urology2011

Comparative Evaluation of the Safety and Efficacy of Long-Term Use of Imidafenacin and Solifenacin in Patients with Overactive Bladder: A Prospective, Open, Randomized, Parallel-Group Trial (the LIST Study).

Masayoshi Zaitsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.